DE68929456D1 - Iontophorische Verabreichung von Medikamenten - Google Patents

Iontophorische Verabreichung von Medikamenten

Info

Publication number
DE68929456D1
DE68929456D1 DE68929456T DE68929456T DE68929456D1 DE 68929456 D1 DE68929456 D1 DE 68929456D1 DE 68929456 T DE68929456 T DE 68929456T DE 68929456 T DE68929456 T DE 68929456T DE 68929456 D1 DE68929456 D1 DE 68929456D1
Authority
DE
Germany
Prior art keywords
agent
membrane
body surface
reservoir
jek
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE68929456T
Other languages
English (en)
Other versions
DE68929456T2 (de
Inventor
Felix Theeuwes
Ronald P Haak
J Richard Gyory
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alza Corp
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of DE68929456D1 publication Critical patent/DE68929456D1/de
Application granted granted Critical
Publication of DE68929456T2 publication Critical patent/DE68929456T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0444—Membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0432—Anode and cathode
    • A61N1/044—Shape of the electrode
DE68929456T 1988-10-03 1989-10-02 Iontophorische Verabreichung von Medikamenten Expired - Lifetime DE68929456T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/252,402 US5080646A (en) 1988-10-03 1988-10-03 Membrane for electrotransport transdermal drug delivery
US252402 1988-10-03

Publications (2)

Publication Number Publication Date
DE68929456D1 true DE68929456D1 (de) 2003-04-17
DE68929456T2 DE68929456T2 (de) 2004-01-08

Family

ID=22955863

Family Applications (2)

Application Number Title Priority Date Filing Date
DE68929456T Expired - Lifetime DE68929456T2 (de) 1988-10-03 1989-10-02 Iontophorische Verabreichung von Medikamenten
DE68929458T Expired - Lifetime DE68929458T2 (de) 1988-10-03 1989-10-02 Membran zur kontrollierung der medikamentenlieferung durch elektrophorese

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE68929458T Expired - Lifetime DE68929458T2 (de) 1988-10-03 1989-10-02 Membran zur kontrollierung der medikamentenlieferung durch elektrophorese

Country Status (14)

Country Link
US (3) US5080646A (de)
EP (2) EP0436658B1 (de)
JP (2) JP2918262B2 (de)
KR (1) KR960014099B1 (de)
AT (2) ATE235284T1 (de)
AU (2) AU627786B2 (de)
CA (2) CA1337300C (de)
DE (2) DE68929456T2 (de)
DK (2) DK175622B1 (de)
FI (1) FI119869B (de)
NO (1) NO318115B1 (de)
NZ (1) NZ230772A (de)
PT (1) PT91890B (de)
WO (1) WO1990003825A1 (de)

Families Citing this family (294)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5250022A (en) * 1990-09-25 1993-10-05 Rutgers, The State University Of New Jersey Iontotherapeutic devices, reservoir electrode devices therefore, process and unit dose
US5080646A (en) * 1988-10-03 1992-01-14 Alza Corporation Membrane for electrotransport transdermal drug delivery
US5549924A (en) * 1987-07-17 1996-08-27 Robin Renee Thill Shlenker Method of forming a membrane, especially a latex or polymer membrane, including a deactivating barrier and indicating layer
US5679399A (en) * 1987-07-17 1997-10-21 Bio Barrier, Inc. Method of forming a membrane, especially a latex or polymer membrane, including multiple discrete layers
US5169382A (en) * 1988-10-03 1992-12-08 Alza Corporation Membrane for electrotransport transdermal drug delivery
US4927408A (en) * 1988-10-03 1990-05-22 Alza Corporation Electrotransport transdermal system
US5496266A (en) * 1990-04-30 1996-03-05 Alza Corporation Device and method of iontophoretic drug delivery
US5147296A (en) * 1988-10-03 1992-09-15 Alza Corporation Membrane for electrotransport transdermal drug delivery
US5234992A (en) * 1989-02-09 1993-08-10 Alza Corporation Electrotransport adhesive
US5240995A (en) * 1989-02-09 1993-08-31 Alza Corporation Electrotransport adhesive
CA2067820A1 (en) * 1989-10-23 1991-04-24 Srinivasan Venkateshwaran Iontophoresis device and method using a rate-controlling membrane
JP2816886B2 (ja) * 1990-03-05 1998-10-27 興和株式会社 生体通電装置
GR1000433B (el) * 1990-04-24 1992-07-30 Alza Corp Συσκευη και μεθοδος ιοντοφορητικης απελευθερωσης φαρμακου.
US5147297A (en) * 1990-05-07 1992-09-15 Alza Corporation Iontophoretic delivery device
US5362308A (en) * 1990-09-25 1994-11-08 Rutgers, The State University Of New Jersey Disposable dosage unit for iontophoresis-facilitated transdermal delivery, related devices and processes
US5677360A (en) * 1991-02-13 1997-10-14 Mitsubishi Rayon Co., Ltd. Hydrophilic polymer alloy, fiber and porous membrane comprising this polymer alloy, and methods for preparing them
US5405317A (en) * 1991-05-03 1995-04-11 Alza Corporation Iontophoretic delivery device
US5402777A (en) * 1991-06-28 1995-04-04 Alza Corporation Methods and devices for facilitated non-invasive oxygen monitoring
US5356632A (en) * 1991-09-12 1994-10-18 S.I. Scientific Innovations Ltd. Transdermal drug delivery device
SE9102778D0 (sv) * 1991-09-25 1991-09-25 Siemens Elema Ab Implanterbar medicinsk anordning
US5421816A (en) * 1992-10-14 1995-06-06 Endodermic Medical Technologies Company Ultrasonic transdermal drug delivery system
CA2126487C (en) * 1993-06-23 2001-05-29 Keiichiro Okabe Iontophoresis device
US5387189A (en) * 1993-12-02 1995-02-07 Alza Corporation Electrotransport delivery device and method of making same
US5508262A (en) * 1993-12-15 1996-04-16 University Of South Florida Interleukin-1 receptor antagonist decreases severity of acute pancreatitis
WO1995027530A1 (en) * 1994-04-08 1995-10-19 Alza Corporation Electrotransport system with ion exchange competitive ion capture
FR2719485B1 (fr) * 1994-05-06 1996-07-12 Lhd Lab Hygiene Dietetique Procédé et dispositif de mesure de la quantité d'un principe actif contenu dans un réservoir.
JP3523334B2 (ja) * 1994-07-02 2004-04-26 久光製薬株式会社 イオントフォレ−シス用プラスター構造体
US5861439A (en) * 1994-11-14 1999-01-19 Alza Corporation Method for enhanced electrotransport agent delivery
FR2726769B1 (fr) * 1994-11-16 1997-01-31 Lhd Lab Hygiene Dietetique Dispositif ionophoretique d'administration transdermique de medicaments et ensemble jetable formant partie d'un tel dispositif
US5855867A (en) * 1995-03-29 1999-01-05 The Curators Of The University Of Missouri Hydroxymethyl phosphine compounds for use as diagnostic and therapeutic pharmaceuticals and method of making same
IL113459A (en) * 1995-04-23 2000-07-16 Electromagnetic Bracing System Electrophoretic cuff apparatus
WO2000023144A1 (en) * 1995-04-23 2000-04-27 Electromagnetic Bracing Systems, Inc. Transdermal active drug delivery system and method
US5853383A (en) * 1995-05-03 1998-12-29 Alza Corporation Preparation for formulations for electrotransport drug delivery
BR9609358A (pt) * 1995-06-05 1999-05-18 Alza Corp Dispositivo para distribuição transdérmica por eletrotransporte fentanil e sufentanil
US6425892B2 (en) 1995-06-05 2002-07-30 Alza Corporation Device for transdermal electrotransport delivery of fentanyl and sufentanil
ZA964320B (en) * 1995-06-05 1997-01-13 Alza Corp Device for transdermal electrotransport delivery of fentanyl and sufentanil
US6216033B1 (en) 1996-05-22 2001-04-10 Alza Corporation Device for transdermal electrotransport delivery of fentanyl and sufentanil
US6881208B1 (en) * 1995-06-05 2005-04-19 Joseph B. Phipps Method and device for transdermal electrotransport delivery of fentanyl and sufentanil
US5747453A (en) * 1995-06-06 1998-05-05 Alza Corporation Method for increasing the electrotransport flux of polypeptides
US5983130A (en) * 1995-06-07 1999-11-09 Alza Corporation Electrotransport agent delivery method and apparatus
US7572252B1 (en) 1995-06-07 2009-08-11 Alza Corporation Electrotransport agent delivery method and apparatus
US5767084A (en) * 1995-10-06 1998-06-16 The Curators Of The University Of Missouri Method of treatment for cystic fibrosis and peptides for same
US6218594B1 (en) 1995-11-08 2001-04-17 University Of South Florida Guinea pig model for leiomyomas
WO1997027844A1 (en) 1996-01-30 1997-08-07 Novagent Oy Composition for transdermal delivery of drugs
US6333189B1 (en) 1996-06-06 2001-12-25 Alza Corporation Method of making an electrotransport device
US6718201B1 (en) 1996-06-07 2004-04-06 Alza Corporation Electrotransport agent delivery method and apparatus
ATE234129T1 (de) 1996-06-18 2003-03-15 Alza Corp Vorrichtung zur verbesserung der transdermalen verabreichung von medikamenten oder der abnahme von körperflüssigkeiten
WO1997048444A1 (en) * 1996-06-19 1997-12-24 Becton Dickinson And Company Iontophoretic delivery of cell adhesion inhibitors
CN1095681C (zh) * 1996-06-20 2002-12-11 久光制药株式会社 一种用于离子电渗疗法的装置结构
US5941843A (en) * 1996-07-12 1999-08-24 Empi, Inc. Iontophoresis electrode
US5857993A (en) * 1996-07-12 1999-01-12 Empi, Inc. Process of making an iontophoresis electrode
US5871461A (en) * 1996-07-12 1999-02-16 Empi, Inc. Method of making an iontophoresis electrode
US6350259B1 (en) * 1996-09-30 2002-02-26 Vyteris, Inc. Selected drug delivery profiles using competing ions
US5906976A (en) * 1996-10-22 1999-05-25 Ramot-University Authority For Applied Research And Industrial Development, Ltd. Method and composition for treating neuronal degeneration
FR2755372B1 (fr) * 1996-11-07 1998-12-24 Elf Aquitaine Dispositif d'ionophorese comportant au moins un ensemble electrode a membrane, pour l'administration transcutanee de principes actifs a un sujet
US6650934B2 (en) 1996-12-17 2003-11-18 Alza Corp Polymeric foam reservoirs for an electrotransport delivery device
US6246904B1 (en) 1996-12-17 2001-06-12 Alza Corporation Electrotransport drug delivery reservoirs containing inert fillers
US6119036A (en) 1997-03-26 2000-09-12 The Board Of Regents Of The University Of Oklahoma Iontophoretic transdermal delivery device
US5976547A (en) * 1997-04-22 1999-11-02 Niblick Pharmaceuticals, Inc. Analgesic and antiphlogistic compositions and therapeutic wrap for topical delivery
US6004577A (en) * 1997-08-12 1999-12-21 Murdock; Thomas O. Enhanced electrotransport of therapeutic agents having polybasic anionic counter ions
US6775569B2 (en) * 1997-11-05 2004-08-10 Hisamitsu Pharmaceutical Co., Inc. Electroporation device for in vivo delivery of therapeutic agents
DE69826705T2 (de) * 1997-11-12 2006-02-23 Alza Corp., Palo Alto Verfahren zur dermalen verabreichung von polypeptiden
JP3980140B2 (ja) * 1997-12-04 2007-09-26 村越 寧根 治療器具
US6918901B1 (en) 1997-12-10 2005-07-19 Felix Theeuwes Device and method for enhancing transdermal agent flux
EP1911488A3 (de) 1997-12-11 2008-12-03 Alza Corporation Vorrichtung zur Verstärkung des Flusses transdermaler Mittel
PT1037687E (pt) 1997-12-11 2008-12-17 Alza Corp Dispositivo para melhoramento de fluxo transdérmico de agente
DK1037686T3 (da) * 1997-12-11 2006-01-02 Alza Corp Apparat til forögelse af transdermal gennemströmning af midler
ATE221400T1 (de) * 1997-12-11 2002-08-15 Alza Corp Vorrichtung zur erhöhung des transdermalen wirkstoffeflusses
US6163720A (en) * 1997-12-18 2000-12-19 Alza Corporation Layered rate controlling membranes for use in an electrotransport device
US6374136B1 (en) * 1997-12-22 2002-04-16 Alza Corporation Anhydrous drug reservoir for electrolytic transdermal delivery device
JP4154017B2 (ja) * 1997-12-30 2008-09-24 久光製薬株式会社 イオントフォレーシス装置および薬物ユニット
US6489306B2 (en) 1998-02-23 2002-12-03 University Of South Florida Method of intranasal gene transfer for protection against respiratory infection
US6059736A (en) * 1998-02-24 2000-05-09 Tapper; Robert Sensor controlled analysis and therapeutic delivery system
US6028102A (en) * 1998-02-24 2000-02-22 Yissum Research Development Company Of The Hebrew University Of Jerusalem Anticonvulsant drugs and pharmaceutical compositions thereof
US6338834B1 (en) 1998-04-30 2002-01-15 The Curators Of The University Of Missouri Melanotropin analogs for potential radiopharmaceuticals for diagnosis and treatment of melanoma
US6344443B1 (en) 1998-07-08 2002-02-05 University Of South Florida Peptide antagonists of tumor necrosis factor alpha
US7605149B1 (en) 1998-07-13 2009-10-20 University Of South Florida Modulation of the phospholipase A2 pathway as a therapeutic
US7002003B1 (en) * 1998-07-30 2006-02-21 University Of South Florida Method for the inhibition of function of STAT transcription factors
US6780397B2 (en) 1998-09-01 2004-08-24 Curators Of The University Of Missouri Biomolecule conjugation strategy using novel water-soluble phosphine-based chelating agents
US20050171021A1 (en) * 1998-11-12 2005-08-04 Cormier Michel J. Buffered drug formulations for transdermal
US20070196490A1 (en) * 1999-01-22 2007-08-23 Powderject Research Limited Method of enhancing needleless transdermal powered drug delivery
US6638974B1 (en) 1999-04-09 2003-10-28 University Of South Florida Ascorbyl esters for the treatment of cancer
US6787318B1 (en) * 1999-06-01 2004-09-07 Roskamp Research Institute, Llc Assay for evaluating the therapeutic effectiveness of agents in reducing Alzheimer's disease pathology
DE60040299D1 (de) * 1999-06-14 2008-10-30 Ford Henry Health System Stickstoffmonoxid-donoren zum induzieren von neurogenese
US7655423B2 (en) * 1999-06-14 2010-02-02 Henry Ford Health System Nitric oxide donors for inducing neurogenesis
US7135498B1 (en) 1999-06-14 2006-11-14 Henry Ford Health System Nitric oxide donors for inducing neurogenesis
US6394994B1 (en) * 1999-08-27 2002-05-28 Vyteris, Inc. Method for testing the ability of an iontophoretic reservoir-electrode to deliver a medicament
US6998232B1 (en) 1999-09-27 2006-02-14 Quark Biotech, Inc. Methods of diagnosing bladder cancer
AU4710401A (en) 1999-12-02 2001-06-18 University Of South Florida Method and composition for treatment of ischemic neuronal reperfusion injury
DE60024312T2 (de) 1999-12-10 2006-08-17 Alza Corp., Mountain View Transdermale Wirkstoffabgabe von makromolekularen Wirkstoffen und Vorrichtung hierfür
WO2002003921A2 (en) * 2000-07-11 2002-01-17 University Of South Florida Bax fragment induced tumor cell death
FR2812218B1 (fr) * 2000-07-28 2003-01-10 Eastman Kodak Co Procede pour ameliorer le fonctionnement d'une membrane d'un dispositif de nanofiltration
US6803060B2 (en) 2000-09-07 2004-10-12 Joe Reyes Composition to boost libido
US20070025958A1 (en) * 2000-10-27 2007-02-01 Hadden John W Vaccine immunotherapy
US20060194242A1 (en) * 2000-10-27 2006-08-31 Hadden John W Immunotherapy for immune suppressed patients
US6553255B1 (en) 2000-10-27 2003-04-22 Aciont Inc. Use of background electrolytes to minimize flux variability during iontophoresis
US7182942B2 (en) * 2000-10-27 2007-02-27 Irx Therapeutics, Inc. Vaccine immunotherapy for immune suppressed patients
US20070154399A1 (en) * 2000-10-27 2007-07-05 Hadden John W Immunotherapy for immune suppressed patients
US20070031372A1 (en) * 2004-08-05 2007-02-08 Hadden John W Vaccine immunotherapy for immune suppressed patients
MXPA03003638A (es) * 2000-10-27 2004-01-26 Immuno Rx Inc Inmunoterapia con vacuna para pacientes inmunosuprimidos.
WO2002081024A1 (en) * 2001-04-04 2002-10-17 Alza Corporation Transdermal electrotransport delivery device including an antimicrobial compatible reservoir composition
US6770622B2 (en) 2001-06-08 2004-08-03 Gary A. Jarvis N-terminally truncated galectin-3 for use in treating cancer
DE10141650C1 (de) 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
CA2498591A1 (en) 2001-10-26 2003-05-01 Immuno-Rx, Inc. Immunotherapy for reversing immune suppression
US7349733B2 (en) 2001-11-02 2008-03-25 Ceramatel, Inc. Iontophoretic drug delivery systems
US7047069B2 (en) 2002-02-04 2006-05-16 Ceramatec, Inc. Iontophoretic fluid delivery device
US6775570B2 (en) 2002-02-04 2004-08-10 Ceramatec, Inc. Iontophoretic treatment device
DE10205373B4 (de) * 2002-02-09 2007-07-19 Aloys Wobben Brandschutz
DE60313353T2 (de) 2002-10-04 2007-08-16 Photokinetix Inc. Photokinetische abgabe von biologisch aktiven subtanzen unter verwendung von pulsierendem inkohaerentem licht.
AU2003284968A1 (en) * 2002-10-25 2004-05-13 University Of South Florida Methods and compounds for disruption of cd40r/cd40l signaling in the treatment of alzheimer's disease
US6872292B2 (en) * 2003-01-28 2005-03-29 Microlin, L.C. Voltage modulation of advanced electrochemical delivery system
US7220778B2 (en) * 2003-04-15 2007-05-22 The General Hospital Corporation Methods and devices for epithelial protection during photodynamic therapy
MXPA06001414A (es) * 2003-08-04 2006-08-25 Johnson & Johnson Metodo y dispositivo para incrementar el flujo de agente transdermico.
US20050049196A1 (en) * 2003-08-29 2005-03-03 Michael Hutchinson Indirect delivery of growth factors into the central nervous system
CA2538904C (en) * 2003-09-12 2013-03-12 Paul Wischmeyer Glutamine for use in treating injury
CA2543084A1 (en) * 2003-10-24 2005-05-12 Alza Corporation Apparatus and method for enhancing transdermal drug delivery
WO2005042054A2 (en) 2003-10-24 2005-05-12 Alza Corporation Pretreatment method and system for enhancing transdermal drug delivery
CA2543280A1 (en) * 2003-10-28 2005-05-19 Alza Corporation Delivery of polymer conjugates of therapeutic peptides and proteins via coated microporjections
KR20070011240A (ko) * 2003-11-13 2007-01-24 알자 코포레이션 경피 송달 시스템 및 방법
ATE370766T1 (de) * 2003-11-19 2007-09-15 Alza Corp Verfahren zur herstellung von polymeren pufferformulierungen für elektrotransport- anwendungen
WO2005059100A2 (en) * 2003-12-12 2005-06-30 New York University Methods and compositions relating to cystatin c
JP2007528369A (ja) * 2003-12-30 2007-10-11 シンドロメクス・リミテッド ３，３，１４，１４−テトラメチルヘキサデカン−１，１６−ジオイック酸の投与法
DE602005025347D1 (de) 2004-01-30 2011-01-27 Quark Pharmaceuticals Inc Oligoribonukleotide und verfahren zu deren anwendung bei der behandlung von fibrotischen leiden und anderen krankheiten
US20050220439A1 (en) * 2004-03-19 2005-10-06 Carton Owen A Interactive multimedia system and method
JP2007532645A (ja) * 2004-04-13 2007-11-15 アルザ コーポレイション フェンタニルに基づく薬剤の経皮送達システム用の器具および方法
WO2005112984A2 (en) * 2004-05-13 2005-12-01 Alza Corporation Apparatus and method for transdermal delivery of parathyroid hormone agents
EP1747672A4 (de) * 2004-05-19 2010-02-17 Alza Corp Verfahren und formulierung für transdermale abgabe von immunologisch aktiven wirkstoffen
US20060030811A1 (en) * 2004-08-03 2006-02-09 Wong Patrick S Method and device for enhancing transdermal agent flux
AR054300A1 (es) * 2004-08-10 2007-06-20 Alza Corp Aparato y sistema de microproyeccion con escaso potencial infeccioso
BRPI0514395A (pt) 2004-08-16 2008-06-10 Quark Biotech Inc uso terapêutico de inibidores de rtp801
AR050608A1 (es) * 2004-08-19 2006-11-08 Alza Corp Aparato y metodo para administracion transdermica de factores de crecimiento endotelial vascular
LT1799269T (lt) 2004-09-28 2016-10-25 Quark Pharmaceuticals, Inc. Oligoribonukleotidai ir jų naudojimo būdai alopecijos, ūminio inkstų nepakankamumo ir kitų ligų gydymui
JP2006116086A (ja) * 2004-10-21 2006-05-11 Tokuyama Corp イオントフォレーシス装置用作用極構造体及びイオントフォレーシス装置
US20060095001A1 (en) * 2004-10-29 2006-05-04 Transcutaneous Technologies Inc. Electrode and iontophoresis device
WO2006055729A1 (en) * 2004-11-16 2006-05-26 Transcutaneous Technologies Inc. Iontophoretic device and method for administering immune response-enhancing agents and compositions
JP4728631B2 (ja) * 2004-11-30 2011-07-20 Ｔｔｉ・エルビュー株式会社 イオントフォレーシス装置
CA2589532A1 (en) * 2004-12-09 2006-06-15 Transcutaneous Technologies Inc. Iontophoresis device
US7590444B2 (en) * 2004-12-09 2009-09-15 Tti Ellebeau, Inc. Iontophoresis device
JP4731931B2 (ja) * 2005-02-03 2011-07-27 Ｔｔｉ・エルビュー株式会社 イオントフォレーシス装置
KR20070101303A (ko) * 2005-02-03 2007-10-16 트랜스큐 테크놀로지스 가부시키가이샤 이온토포레시스 장치
AU2006213994A1 (en) * 2005-02-16 2006-08-24 Alza Corporation Microprojection arrays with improved biocompatibility
AU2006214236A1 (en) * 2005-02-16 2006-08-24 Alza Corporation Apparatus and method for transdermal delivery of erythropoetin-based agents
TW200640526A (en) * 2005-02-24 2006-12-01 Alza Corp Transdermal electrotransport drug delivery systems with reduced abuse potential
JP4793806B2 (ja) 2005-03-22 2011-10-12 Ｔｔｉ・エルビュー株式会社 イオントフォレーシス装置
JP2006296511A (ja) * 2005-04-15 2006-11-02 Transcutaneous Technologies Inc 外用剤、外用剤の塗布方法、イオントフォレーシス装置及び経皮パッチ
CA2610245A1 (en) * 2005-06-02 2006-12-07 Alza Corporation Method for terminal sterilization of transdermal delivery devices
JP2006334164A (ja) * 2005-06-02 2006-12-14 Transcutaneous Technologies Inc イオントフォレーシス装置及びその制御方法
US20060280645A1 (en) * 2005-06-02 2006-12-14 Scott Sellers Method for terminal sterilization of transdermal delivery devices
JP2006346368A (ja) * 2005-06-20 2006-12-28 Transcutaneous Technologies Inc イオントフォレーシス装置及びその製造方法
JP2007000342A (ja) * 2005-06-23 2007-01-11 Transcutaneous Technologies Inc 複数薬剤の投与量および投与時期を制御するイオントフォレーシス装置
US20090214625A1 (en) * 2005-07-15 2009-08-27 Mizuo Nakayama Drug delivery patch
KR100719095B1 (ko) * 2005-07-29 2007-05-17 성균관대학교산학협력단 연료 확산속도 제어물질층을 포함하여 메탄올 크로스오버현상을 억제시킨 직접 메탄올 연료전지
US8386030B2 (en) * 2005-08-08 2013-02-26 Tti Ellebeau, Inc. Iontophoresis device
US8295922B2 (en) 2005-08-08 2012-10-23 Tti Ellebeau, Inc. Iontophoresis device
US20070088332A1 (en) * 2005-08-22 2007-04-19 Transcutaneous Technologies Inc. Iontophoresis device
WO2007023907A1 (ja) * 2005-08-24 2007-03-01 Transcu Ltd. 冷凍型イオントフォレーシス用電極構造体
US20070048362A1 (en) * 2005-08-29 2007-03-01 Transcutaneous Technologies Inc. General purpose electrolyte solution composition for iontophoresis
JPWO2007029611A1 (ja) * 2005-09-06 2009-03-19 Ｔｔｉ・エルビュー株式会社 イオントフォレーシス装置
US20070112294A1 (en) * 2005-09-14 2007-05-17 Transcutaneous Technologies Inc. Iontophoresis device
BRPI0616165A2 (pt) 2005-09-15 2011-06-07 Tti Ellebeau Inc dispositivo de iontoforese do tipo de haste
CN101262905A (zh) * 2005-09-16 2008-09-10 Tti优而美株式会社 探针式离子电渗疗装置
JPWO2007037324A1 (ja) * 2005-09-28 2009-04-09 Ｔｔｉ・エルビュー株式会社 乾燥型イオントフォレーシス用電極構造体
US20070073212A1 (en) * 2005-09-28 2007-03-29 Takehiko Matsumura Iontophoresis apparatus and method to deliver active agents to biological interfaces
EP1941929A1 (de) * 2005-09-30 2008-07-09 Tti Ellebeau, Inc. Elektrodenstruktur für iontophorese mit einem formgedächtnis-separator und diese enthaltende iontophorese-vorrichtung
JPWO2007037476A1 (ja) * 2005-09-30 2009-04-16 Ｔｔｉ・エルビュー株式会社 睡眠導入剤と興奮剤の投与量および投与時期を制御するイオントフォレーシス装置
US7574256B2 (en) * 2005-09-30 2009-08-11 Tti Ellebeau, Inc. Iontophoretic device and method of delivery of active agents to biological interface
US20070135754A1 (en) * 2005-09-30 2007-06-14 Hidero Akiyama Electrode assembly for iontophoresis for administering active agent enclosed in nanoparticle and iontophoresis device using the same
WO2007041115A1 (en) * 2005-09-30 2007-04-12 Tti Ellebeau Inc. Method and system to detect malfunctions in an iontophoresis device that delivers active agents to biological interfaces
KR20080066712A (ko) * 2005-09-30 2008-07-16 티티아이 엘뷰 가부시키가이샤 관능화된 미세바늘 경피 약물 전달 시스템, 장치 및 방법
AU2006299520A1 (en) * 2005-09-30 2007-04-12 Tti Ellebeau, Inc. Iontophoresis device to deliver multiple active agents to biological interfaces
JP2009509675A (ja) * 2005-09-30 2009-03-12 Ｔｔｉ・エルビュー株式会社 新規薬学的ビヒクルを用いる経皮薬剤送達システム、装置、及び方法
JP2009509659A (ja) * 2005-09-30 2009-03-12 Ｔｔｉ・エルビュー株式会社 生体界面への活性物質の送達のイオントフォレーシス装置及び方法
JP2009509677A (ja) * 2005-09-30 2009-03-12 Ｔｔｉ・エルビュー株式会社 小胞封入活性物質のイオントフォレーシス送達
US20070197955A1 (en) * 2005-10-12 2007-08-23 Transcutaneous Technologies Inc. Mucous membrane adhesion-type iontophoresis device
US20080033338A1 (en) * 2005-12-28 2008-02-07 Smith Gregory A Electroosmotic pump apparatus and method to deliver active agents to biological interfaces
WO2007079193A2 (en) * 2005-12-30 2007-07-12 Tti Ellebeau, Inc. Iontophoretic systems, devices, and methods of delivery of active agents to biological interface
WO2007079189A2 (en) * 2005-12-30 2007-07-12 Tti Ellebeau, Inc. System and method for remote based control of an iontophoresis device
EP1981910B1 (de) 2006-01-13 2013-06-26 A Chan Holding B.V. Verfahren zur identifikation von einem inhibitor der wechselwirkung zwischen glypican und sclerostin
UY30097A1 (es) 2006-01-20 2007-08-31 Atugen Ag Usos terapeuticos de inhibidores de rtp801
CA2680690A1 (en) * 2006-03-15 2007-09-20 Alza Corporation Apparatus and method for transdermal delivery of parathyroid hormone agents to prevent or treat osteopenia
WO2007123707A1 (en) * 2006-03-30 2007-11-01 Tti Ellebeau, Inc. Controlled release membrane and methods of use
US20080004671A1 (en) * 2006-06-28 2008-01-03 Alza Corporation Vagus nerve stimulation via orally delivered apparatus
US20080009782A1 (en) * 2006-06-28 2008-01-10 Alza Corporation Methods and Devices for Transdermal Electrotransport Delivery of Lofentanil and Carfentanil
KR20090060272A (ko) 2006-09-05 2009-06-11 티티아이 엘뷰 가부시키가이샤 화합물의 이온 영동 특성을 평가하기 위한 임피던스 시스템, 장치 및 방법
EP2061552A2 (de) 2006-09-05 2009-05-27 Tti Ellebeau, Inc. Nicht destruktive systeme, vorrichtungen und verfahren zur bewertung von iontophorese-wirkstoffverabreichungsgeräten
WO2008030497A2 (en) * 2006-09-05 2008-03-13 Tti Ellebeau, Inc. Transdermal drug delivery systems, devices, and methods using inductive power supplies
US20080260678A1 (en) * 2006-10-10 2008-10-23 University Of Colorado Molecular band-aid
JP2010507387A (ja) 2006-10-25 2010-03-11 クアーク・ファーマスーティカルス、インコーポレイテッド 新規のｓｉＲＮＡおよびその使用方法
CA2671069A1 (en) 2006-12-01 2008-06-12 Tti Ellebeau, Inc. Systems, devices, and methods for powering and/or controlling devices, for instance transdermal delivery devices
WO2008087884A1 (ja) 2007-01-16 2008-07-24 Tti Ellebeau, Inc. 薬物投与量の予測方法及びそのプログラム
US20080188791A1 (en) * 2007-02-02 2008-08-07 Difiore Attilio E Active iontophoresis delivery system
RU2482841C2 (ru) * 2007-05-18 2013-05-27 ТиТиАй Эллебо, Инк. Устройства для трансдермальной доставки, обеспечивающие улучшенное высвобождение действующего начала через биологическую поверхность
US8197844B2 (en) * 2007-06-08 2012-06-12 Activatek, Inc. Active electrode for transdermal medicament administration
US8729121B2 (en) 2007-06-25 2014-05-20 Adhezion Biomedical, Llc Curing accelerator and method of making
EP2164418B1 (de) * 2007-06-27 2014-01-08 The General Hospital Corporation Vorrichtung zur optischen unterdrückung einer photodynamischen therapie
SI2170403T1 (sl) 2007-06-27 2014-07-31 Quark Pharmaceuticals, Inc. Sestavki in postopki za inhibicijo ekspresije pro-apoptotskih genov
CN103898110A (zh) 2007-10-03 2014-07-02 夸克制药公司 新siRNA结构
EP2211727B1 (de) 2007-11-14 2014-03-12 Adhezion Biomedical, LLC Cyanoacrylat-gewebekleber
US8862223B2 (en) 2008-01-18 2014-10-14 Activatek, Inc. Active transdermal medicament patch and circuit board for same
EP2106791A1 (de) 2008-03-31 2009-10-07 Biotempt B.V. Glutamin oder Glutamine enthaltendes Dipeptide in einer spezifischen Dosierung für die Behandlung von Entzündungen
CA2727015A1 (en) * 2008-06-04 2009-12-10 Coda Therapeutics, Inc. Treatment of pain with gap junction modulation compounds
US8198344B2 (en) 2008-06-20 2012-06-12 Adhezion Biomedical, Llc Method of preparing adhesive compositions for medical use: single additive as both the thickening agent and the accelerator
US8293838B2 (en) 2008-06-20 2012-10-23 Adhezion Biomedical, Llc Stable and sterile tissue adhesive composition with a controlled high viscosity
US20110117047A1 (en) 2008-06-23 2011-05-19 Adhezion Biomedical, Llc Cyanoacrylate tissue adhesives with desirable permeability and tensile strength
CA2736495A1 (en) * 2008-09-10 2010-03-18 Gregory A. Smith Apparatus and method to dispense hpc-based viscous liquids into porous substrates, e.g., continuous web-based process
US9254133B2 (en) 2008-10-31 2016-02-09 Adhezion Biomedical, Llc Sterilized liquid compositions of cyanoacrylate monomer mixtures
US8609128B2 (en) 2008-10-31 2013-12-17 Adhezion Biomedical, Llc Cyanoacrylate-based liquid microbial sealant drape
US8652510B2 (en) 2008-10-31 2014-02-18 Adhezion Biomedical, Llc Sterilized liquid compositions of cyanoacrylate monomer mixtures
WO2010080452A2 (en) 2008-12-18 2010-07-15 Quark Pharmaceuticals, Inc. siRNA COMPOUNDS AND METHODS OF USE THEREOF
US8961492B2 (en) 2009-02-12 2015-02-24 Incube Labs, Llc System and method for controlling the iontophoretic delivery of therapeutic agents based on user inhalation
US8190252B2 (en) 2009-02-12 2012-05-29 Incube Labs, Llc Iontophoretic system for transdermal delivery of active agents for therapeutic and medicinal purposes
US9095503B2 (en) 2009-02-12 2015-08-04 Incube Labs, Llc System and method for biphasic transdermal iontophreotic delivery of therapeutic agents
JP5653942B2 (ja) 2009-02-26 2015-01-14 ザ ユニバーシティ オブ ノース キャロライナ アット チャペル ヒル 介入薬剤送達システム
WO2010111598A1 (en) 2009-03-26 2010-09-30 Henry Ford Health System Methods for improving neurological outcome after neural injury and neurodegenerative disease
US20100286590A1 (en) * 2009-05-08 2010-11-11 Isis Biopolymer Llc Iontophoretic device with improved counterelectrode
US20110092881A1 (en) * 2009-05-08 2011-04-21 Isis Biopolymer Inc. Iontophoretic device with contact sensor
DK3276004T3 (da) 2009-06-08 2020-04-06 Quark Pharmaceuticals Inc Fremgangsmåder til behandling af kronisk nyresygdom
WO2010144424A2 (en) * 2009-06-09 2010-12-16 Tti Ellebeau, Inc. Long life high capacity electrode, device, and method of manufacture
US8903485B2 (en) 2009-08-06 2014-12-02 Incube Labs, Llc Patch and patch assembly for iontophoretic transdermal delivery of active agents for therapeutic and medicinal purposes
CN102597239A (zh) 2009-11-26 2012-07-18 夸克医药公司 包含末端取代的sirna化合物
US8685038B2 (en) 2009-12-07 2014-04-01 Incube Labs, Llc Iontophoretic apparatus and method for marking of the skin
TWI543763B (zh) 2009-12-09 2016-08-01 日東電工股份有限公司 Ｈｓｐ４７表現之調節
EP2862929B1 (de) 2009-12-09 2017-09-06 Quark Pharmaceuticals, Inc. Zusammensetzungen und Verfahren zur Behandlung von Erkrankungen, Störungen oder Läsionen des ZNS
JP5463136B2 (ja) * 2009-12-22 2014-04-09 帝國製薬株式会社 イオントフォレーシス療法に用いる電極装置
WO2011084193A1 (en) 2010-01-07 2011-07-14 Quark Pharmaceuticals, Inc. Oligonucleotide compounds comprising non-nucleotide overhangs
US8986279B2 (en) 2010-02-10 2015-03-24 Incube Labs, Llc Methods and architecture for power optimization of iontophoretic transdermal drug delivery
US9486005B2 (en) 2010-02-22 2016-11-08 Smiti Vaid Gupta Agents and mechanisms for treating hypercholesterolemia
CN107115326B (zh) 2010-04-13 2021-01-22 雷尔玛达治疗股份有限公司 1-甲基-n-(2,6-二甲苯基)-2-哌啶甲酰胺的皮肤用药物组合物及其使用方法
US9309019B2 (en) 2010-05-21 2016-04-12 Adhezion Biomedical, Llc Low dose gamma sterilization of liquid adhesives
JP5824515B2 (ja) 2010-06-24 2015-11-25 クォーク ファーマシューティカルズ インコーポレーティッドＱｕａｒｋ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． Ｒｈｏａに対する二本鎖ｒｎａ化合物およびその使用
US20140134231A1 (en) 2010-10-11 2014-05-15 Sanford-Burnham Medical Research Institute Mir-211 expression and related pathways in human melanoma
WO2012078536A2 (en) 2010-12-06 2012-06-14 Quark Pharmaceuticals, Inc. Double stranded oligonucleotide compounds comprising positional modifications
CN103562387A (zh) 2011-03-03 2014-02-05 夸克医药公司 Toll样受体途径的寡核苷酸调剂
US9796979B2 (en) 2011-03-03 2017-10-24 Quark Pharmaceuticals Inc. Oligonucleotide modulators of the toll-like receptor pathway
JP6000287B2 (ja) 2011-03-03 2016-09-28 クォーク ファーマシューティカルズ インコーポレーティッドＱｕａｒｋ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． 肺疾患および損傷を治療するための組成物および方法
US8781571B2 (en) 2011-03-31 2014-07-15 Incline Therapeutics, Inc. Switch validation circuit and method
US8428709B1 (en) 2012-06-11 2013-04-23 Incline Therapeutics, Inc. Current control for electrotransport drug delivery
US9731121B2 (en) 2011-03-31 2017-08-15 Incline Therapeutics, Inc. Switch validation circuit and method
US8428708B1 (en) 2012-05-21 2013-04-23 Incline Therapeutics, Inc. Self-test for analgesic product
WO2012154704A2 (en) 2011-05-06 2012-11-15 Incube Labs, Llc System and method for biphasic transdermal iontophoretic delivery of therapeutic agents for the control of addictive cravings
US20140227293A1 (en) 2011-06-30 2014-08-14 Trustees Of Boston University Method for controlling tumor growth, angiogenesis and metastasis using immunoglobulin containing and proline rich receptor-1 (igpr-1)
US20130090633A1 (en) * 2011-10-07 2013-04-11 University Of Southern California Osmotic patch pump
EP2776565A1 (de) 2011-11-08 2014-09-17 Quark Pharmaceuticals, Inc. Verfahren und zusammensetzungen und zur behandlung von erkrankungen, störungen oder läsionen des nervensystems
CN104080480A (zh) 2012-01-01 2014-10-01 奇比艾企业有限公司 用于选择性递送治疗剂和诊断剂的endo180靶向微粒
AU2013208012A1 (en) 2012-01-12 2014-07-03 Quark Pharmaceuticals, Inc. Combination therapy for treating hearing and balance disorders
EP3269372B1 (de) 2012-01-19 2019-06-12 Hybrid Medical, LLC Topische therapeutische formulierungen
US9314571B1 (en) * 2012-02-10 2016-04-19 Mphase Technologies, Inc. Drug delivery system
CN104736709A (zh) 2012-03-27 2015-06-24 科达治疗公司 基于钙粘蛋白调节的组合物和治疗
AU2013263502B2 (en) 2012-05-18 2018-02-08 Otago Innovation Limited Combination treatments and compositions for wound healing
JP6202287B2 (ja) 2012-05-23 2017-09-27 セリックスビオ プライヴェート リミテッド 炎症性腸疾患の治療のための組成物及び方法
JP2015518854A (ja) 2012-05-23 2015-07-06 セリックスビオ プライヴェート リミテッド 多発性硬化症の治療のための組成物および方法
WO2013173923A1 (en) 2012-05-25 2013-11-28 Diamedica, Inc. Formulations of human tissue kallikrein-1 for parenteral delivery and related methods
EP2854841B1 (de) 2012-06-04 2017-02-22 Diamedica Inc. Kallikrein-1-glycosylierungsisoformen aus menschlichem gewebe
JP5918909B2 (ja) 2012-06-25 2016-05-18 ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッドＴｈｅ Ｂｒｉｇｈａｍ ａｎｄ Ｗｏｍｅｎ’ｓ Ｈｏｓｐｉｔａｌ， Ｉｎｃ． 標的化治療薬
US9611473B2 (en) 2012-09-12 2017-04-04 Quark Pharmaceuticals, Inc. Double-stranded nucleic acid compounds
EP2895608B1 (de) 2012-09-12 2018-12-05 Quark Pharmaceuticals, Inc. Doppelsträngige oligonukleotidmoleküle an p53 und verfahren zur verwendung davon
BR112015004747A2 (pt) 2012-09-12 2017-11-21 Quark Pharmaceuticals Inc moléculas oligonucleotídicas de fita dupla para p53 e métodos de uso das mesmas
AU2013370966A1 (en) 2012-12-24 2015-06-18 Neurogastrx, Inc. Methods for treating GI tract disorders
PL2968470T3 (pl) 2013-03-12 2021-05-31 The General Hospital Corporation Zmodyfikowane białka stanowiące substancję hamującą rozwój przewodów müllera (mis) i ich zastosowania do leczenia chorób
WO2014201372A1 (en) 2013-06-13 2014-12-18 Health Enhancement Products, Inc. Compounds and methods for affecting cytokines
WO2015020960A1 (en) 2013-08-09 2015-02-12 Novartis Ag Novel lncrna polynucleotides
US20160228698A1 (en) * 2013-09-19 2016-08-11 Koninklijke Philips N.V. Treatment device for the skin using radio-frequency electric current
EP3079712B1 (de) 2013-12-11 2022-02-02 The General Hospital Corporation Verwendung von anti-müller-hormon (amh)-proteine zur kontrazeption und ovariellen reservekonservierung
US9421297B2 (en) 2014-04-02 2016-08-23 Adhezion Biomedical, Llc Sterilized compositions of cyanoacrylate monomers and naphthoquinone 2,3-oxides
WO2015200369A1 (en) 2014-06-24 2015-12-30 Neurogastrx, Inc. Prodrugs of metopimazine
CA2976314C (en) 2014-09-26 2021-02-23 Cellix Bio Private Limited Compositions and methods for the treatment of epilepsy and neurological disorders
JP6698643B2 (ja) 2014-09-29 2020-05-27 セリックス バイオ プライヴェート リミテッドＣｅｌｌｉｘ Ｂｉｏ Ｐｒｉｖａｔｅ Ｌｉｍｉｔｅｄ 多発性硬化症の治療のための組成物及び方法
WO2016067297A1 (en) 2014-10-27 2016-05-06 Cellix Bio Private Limited Salts of valproic acid with piperazine, ethylenediamine, lysine and/or eicosapentaenoic ecid (epa) amine derivatives for the treatment of epilepsy
WO2016098119A1 (en) 2014-10-27 2016-06-23 Cellix Bio Private Limited Three component salts of fumaric acid monomethyl ester with piperazine or ethylene diamine for the treatment of multiple sclerosis
CN107207411A (zh) 2014-12-01 2017-09-26 塞尔利克斯生物私人有限公司 用于治疗多发性硬化的组合物和方法
SG10201906474QA (en) 2015-02-09 2019-09-27 Cellix Bio Private Ltd Compositions and methods for the treatment of mucositis
CA3011687A1 (en) 2015-02-16 2016-08-25 Zivo Bioscience, Inc. Methods of modulating immune and inflammatory responses via administration of an algal biomass
FR3034017B1 (fr) * 2015-03-24 2018-11-02 Feeligreen Matrice polymerique adhesive pour iontophorese et dispositif pour l'iontophorese comprenant ladite matrice
US11806375B2 (en) 2016-02-16 2023-11-07 Zivo Bioscience, Inc. Nutritional support for animals via administration of an algal derived supplement
EP3416618A1 (de) 2016-02-19 2018-12-26 ZP Opco, Inc. Verfahren zum schnellen erreichen therapeutischer konzentrationen von triptanen zur behandlung von migräne
MX2019001360A (es) 2016-08-11 2019-06-03 Cellix Bio Private Ltd Composiciones y metodos para el tratamiento de sindrome de intestino irritable.
EP3522873B1 (de) 2016-10-04 2022-03-16 Cellix Bio Private Limited Zusammensetzungen und verfahren zur behandlung von xerostomie
KR102567090B1 (ko) 2016-11-28 2023-08-17 셀릭스 바이오 프라이빗 리미티드 곰팡이 감염의 치료를 위한 조성물 및 방법
EP3554494A4 (de) 2016-12-19 2021-02-17 Cellixbio Private Limited Zusammensetzungen und verfahren zur behandlung von entzündungen
US11857608B2 (en) 2017-03-09 2024-01-02 Diamedica Inc. Dosage forms of tissue kallikrein 1
US11660264B2 (en) 2017-08-23 2023-05-30 Emergex USA Corporation Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines and cluster headaches
AU2017428907B2 (en) 2017-08-23 2021-12-16 Zosano Pharma Corporation Method of rapidly achieving therapeutic concentrations of zolmitriptan for treatment of migraines and cluster headaches
EP3697535B1 (de) 2017-10-18 2023-04-26 Nuclera Nucleics Ltd Digitale mikrofluidische vorrichtungen mit doppelsubstraten mit dünnschichttransistoren und kapazitiver messung
RU2761436C1 (ru) 2017-11-17 2021-12-08 Целликс Био Прайвет Лимитед Композиции и способы лечения нарушений со стороны органа зрения
WO2019097381A1 (en) 2017-11-17 2019-05-23 Cellix Bio Private Limited Compounds, compositions and methods for treatment of eye disorders and skin diseases
US11660265B2 (en) 2018-06-28 2023-05-30 Emergex USA Corporation Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines and cluster headaches
US11724024B2 (en) * 2018-07-24 2023-08-15 University Of Maryland, College Park Inverted battery devices, and systems and methods for use thereof
US11353759B2 (en) 2018-09-17 2022-06-07 Nuclera Nucleics Ltd. Backplanes with hexagonal and triangular electrodes
US11511096B2 (en) 2018-10-15 2022-11-29 E Ink Corporation Digital microfluidic delivery device
US10836757B1 (en) 2020-04-02 2020-11-17 Neurogastrx, Inc. Polymorphic forms of metopimazine
EP3922720A1 (de) 2020-06-09 2021-12-15 Universidad de Murcia Therapie zur verhinderung unerwünschter kardialer remodellierung nach einem akuten myokardinfarkt
WO2022147307A1 (en) * 2020-12-30 2022-07-07 Georgia Tech Research Corporation Methods and devices for inducement of sweat for medical diagnostics
US20220265582A1 (en) 2021-02-24 2022-08-25 Universitätsspital Basel Effects of mescaline and of mescaline analogs (scalines) to assist psychotherapy
US11801256B2 (en) 2021-06-08 2023-10-31 Universitätsspital Basel Antidepressant-psilocybin co-treatment to assist psychotherapy

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US250878A (en) * 1881-12-13 brush
GB174605A (en) * 1921-01-27 1923-04-19 Edith Amy Cook Improvements in cow milkers
US3797494A (en) * 1969-04-01 1974-03-19 Alza Corp Bandage for the administration of drug by controlled metering through microporous materials
US4144317A (en) * 1975-05-30 1979-03-13 Alza Corporation Device consisting of copolymer having acetoxy groups for delivering drugs
US4274420A (en) * 1975-11-25 1981-06-23 Lectec Corporation Monitoring and stimulation electrode
US4325367A (en) * 1977-06-13 1982-04-20 Robert Tapper Iontophoretic treatment apparatus
CA1153427A (en) * 1978-12-11 1983-09-06 Patrick T. Cahalan Tape electrode
US4406658A (en) * 1981-03-06 1983-09-27 Medtronic, Inc. Iontophoretic device with reversible polarity
JPS5810066A (ja) * 1981-07-10 1983-01-20 株式会社アドバンス イオントフオレ−ゼ用プラスタ−構造体
US4419092A (en) * 1981-11-06 1983-12-06 Motion Control, Inc. Iontophoretic electrode structure
US4457748A (en) * 1982-01-11 1984-07-03 Medtronic, Inc. Non-invasive diagnosis method
US4622031A (en) * 1983-08-18 1986-11-11 Drug Delivery Systems Inc. Indicator for electrophoretic transcutaneous drug delivery device
US4731926A (en) * 1985-02-19 1988-03-22 Drug Delivery Systems Inc. Method of manufacturing disposable and/or replenishable transdermal drug applicators
US4557723A (en) * 1983-08-18 1985-12-10 Drug Delivery Systems Inc. Applicator for the non-invasive transcutaneous delivery of medicament
US4708716A (en) * 1983-08-18 1987-11-24 Drug Delivery Systems Inc. Transdermal drug applicator
US4640689A (en) * 1983-08-18 1987-02-03 Drug Delivery Systems Inc. Transdermal drug applicator and electrodes therefor
US4573996A (en) * 1984-01-03 1986-03-04 Jonergin, Inc. Device for the administration of an active agent to the skin or mucosa
US4588580B2 (en) * 1984-07-23 1999-02-16 Alaz Corp Transdermal administration of fentanyl and device therefor
US4904247A (en) * 1984-08-31 1990-02-27 Kendall Company Pressure-sensitive hydrophilic laminate structures for use in wound dressing, transdermal and topical drug delivery
US4747819A (en) * 1984-10-29 1988-05-31 Medtronic, Inc. Iontophoretic drug delivery
US4702732A (en) * 1984-12-24 1987-10-27 Trustees Of Boston University Electrodes, electrode assemblies, methods, and systems for tissue stimulation and transdermal delivery of pharmacologically active ligands
US4673565A (en) * 1985-05-03 1987-06-16 E. I. Du Pont De Nemours And Company Pharmaceutical compositions containing hollow fine tubular drug delivery systems
US4645502A (en) * 1985-05-03 1987-02-24 Alza Corporation Transdermal delivery of highly ionized fat insoluble drugs
GB8512358D0 (en) * 1985-05-16 1985-06-19 Euro Celtique Sa Transdermal delivery system
JPS6222662A (ja) * 1985-07-19 1987-01-30 林原　健 イオン導入電子治療器
US4722726A (en) * 1986-02-12 1988-02-02 Key Pharmaceuticals, Inc. Method and apparatus for iontophoretic drug delivery
ATE71287T1 (de) * 1986-06-13 1992-01-15 Alza Corp Aktivierung eines transdermalen drogenabgabesystems durch feuchtigkeit.
IE60941B1 (en) * 1986-07-10 1994-09-07 Elan Transdermal Ltd Transdermal drug delivery device
JPS63102768A (ja) * 1986-10-20 1988-05-07 山之内製薬株式会社 イオントフオレ−シス用の新規プラスタ−構造体
US4731049A (en) * 1987-01-30 1988-03-15 Ionics, Incorporated Cell for electrically controlled transdermal drug delivery
US4878892A (en) * 1987-02-10 1989-11-07 Drug Delivery Systems Inc. Electrolytic transdermal delivery of polypeptides
US4940456A (en) * 1987-02-10 1990-07-10 Dan Sibalis Electrolytic transdermal delivery of proteins
US5080646A (en) * 1988-10-03 1992-01-14 Alza Corporation Membrane for electrotransport transdermal drug delivery
US4927408A (en) * 1988-10-03 1990-05-22 Alza Corporation Electrotransport transdermal system
US5169382A (en) * 1988-10-03 1992-12-08 Alza Corporation Membrane for electrotransport transdermal drug delivery
US5006108A (en) * 1988-11-16 1991-04-09 Noven Pharmaceuticals, Inc. Apparatus for iontophoretic drug delivery
US5088977A (en) * 1988-12-21 1992-02-18 Drug Delivery Systems Inc. Electrical transdermal drug applicator with counteractor and method of drug delivery
US5023085A (en) * 1989-11-29 1991-06-11 Pfizer Inc. Transdermal flux enhancers in combination with iontophoresis in topical administration of pharmaceuticals
US6382529B1 (en) * 2001-09-28 2002-05-07 Sheng-Li Wu Water sprayer

Also Published As

Publication number Publication date
AU2987692A (en) 1993-02-11
DK175622B1 (da) 2004-12-27
DK59491A (da) 1991-04-03
DK59491D0 (da) 1991-04-03
FI119869B (fi) 2009-04-30
DK200401287A (da) 2004-08-26
WO1990003825A9 (en) 2011-08-25
FI911589A0 (fi) 1991-04-02
EP0436658A1 (de) 1991-07-17
DE68929458D1 (de) 2003-04-30
JP3638805B2 (ja) 2005-04-13
NZ230772A (en) 1991-04-26
CA1337300C (en) 1995-10-10
EP0931564B1 (de) 2003-03-12
EP0931564A1 (de) 1999-07-28
AU627786B2 (en) 1992-09-03
EP0436658B1 (de) 2003-03-26
JP2918262B2 (ja) 1999-07-12
DE68929458T2 (de) 2004-03-11
DE68929456T2 (de) 2004-01-08
JPH04505861A (ja) 1992-10-15
PT91890A (pt) 1990-04-30
KR960014099B1 (ko) 1996-10-14
JPH11216192A (ja) 1999-08-10
ATE234130T1 (de) 2003-03-15
AU4425489A (en) 1990-05-01
NO911186D0 (no) 1991-03-25
KR900701349A (ko) 1990-12-01
WO1990003825A1 (en) 1990-04-19
US5322502A (en) 1994-06-21
US5080646A (en) 1992-01-14
ATE235284T1 (de) 2003-04-15
AU658246B2 (en) 1995-04-06
DK175827B1 (da) 2005-03-14
CA1336781C (en) 1995-08-22
PT91890B (pt) 1995-08-09
NO318115B1 (no) 2005-02-07
US5169383A (en) 1992-12-08
NO911186L (no) 1991-06-03

Similar Documents

Publication Publication Date Title
DE68929456D1 (de) Iontophorische Verabreichung von Medikamenten
US5990179A (en) Composition and method of enhancing electrotransport agent delivery
JP4054890B2 (ja) イオン浸透療法による薬剤投与の装置と方法
US4927408A (en) Electrotransport transdermal system
NO923591L (no) Ioneforetisk avgivelsesanordning
ATE135928T1 (de) Elektrolytische zuführung von polypeptiden durch die haut
EP0725664A4 (de) Wegwerfbare dosierungseinheit zur iontophoretischen verabreichung von medikamenten
CN101309724A (zh) 具有低滥用潜力的透皮电转运药物递送系统
KR20030070582A (ko) 경피 전기운반 장치 및 그 제조 방법
AU8048387A (en) Transdermal administration of amines
ES8600925A1 (es) Procedimiento para la obtencion de una composicion para el tratamiento de cabello a base de resina carboxilica

Legal Events

Date Code Title Description
8364 No opposition during term of opposition